Skip to content

Study · Animal study (in vivo) · rabbit · 2022

5 results

Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93+/CD34+ cells for endothelialization.

Xiao W, Chen W, Wang Y, Zhang C, Zhang X, Zhang S, Wu W

Science advances13 Jul 2022Cited by 21 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits, vascular grafts patterned with dimeric thymosin β4 (DTβ4) contributed to a high patency rate.

    In plain wordsIn rabbits, vascular grafts carrying a dimeric form of thymosin β4 stayed open at a high rate.

    Outcome
    IncreaseGraft patency
    Study

    rabbitn: not reported in source

    carotid artery graft
    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated · conjugated to implanted vascular graftAs given in this study (rabbit).

    Source sentences

    Summary
    Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedent…
    1 context sentence
    Summary · context
    We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In rabbits, grafts patterned with DTβ4 acquired carotid arterial regeneration.

    In plain wordsIn rabbits, grafts carrying a dimeric form of thymosin β4 were followed by regrowth of the carotid artery.

    Outcome
    IncreaseCarotid arterial regeneration
    Study

    rabbitn: not reported in source

    carotid artery graft
    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated · conjugated to implanted vascular graftAs given in this study (rabbit).

    Source sentences

    Summary
    Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedent…
    1 context sentence
    Summary · context
    We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In the graft model, the authors state that DTβ4 had antiplatelet effects and inhibited fibrinogenesis.

    In plain wordsIn this graft model, the authors report that a dimeric form of thymosin β4 reduced platelet activity and fibrin formation.

    Outcome
    DecreasePlatelet activity and fibrinogenesis
    Study

    rabbitn: not reported in source

    carotid artery graft
    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated · conjugated to implanted vascular graftAs given in this study (rabbit).

    Source sentences

    Summary
    Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedent…
    1 context sentence
    Summary · context
    We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate.
  4. 04AnimalAnimal study (in vivo)Mechanism

    In the graft model, the authors state that DTβ4 recruited circulating progenitor cells.

    In plain wordsIn this graft model, the authors report that a dimeric form of thymosin β4 attracted circulating progenitor cells.

    Outcome
    IncreaseRecruitment of circulating progenitor cells
    Study

    rabbitn: not reported in source

    carotid artery graft
    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated · conjugated to implanted vascular graftAs given in this study (rabbit).

    Source sentences

    Summary
    Furthermore, highly porous structures enabled 3D patterning of conjugated heparin-binding peptide, dimeric thymosin β4 (DTβ4), which played key roles in antiplatelets, fibrinogenesis inhibition, and recruiting circulating progenitor cells, thereafter contributed to high patency rate, and unprecedent…
    1 context sentence
    Summary · context
    We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate.
  5. 05AnimalAnimal study (in vivo)Mechanism

    In the DTβ4 graft model, single-cell RNA sequencing and cell tracing identified myeloid-derived CD93+/CD34+ progenitor cells as the main contributor to endothelium regeneration.

    In plain wordsIn rabbits with these grafts, a subset of progenitor cells was identified as the main source of the new vessel lining.

    Outcome
    Not applicableCell source of endothelium regeneration
    Study

    rabbitn: not reported in source

    carotid artery graft
    Outcome group
    Vascular function · Cardiovascular
    Studied dose
    Dose not stated · conjugated to implanted vascular graftAs given in this study (rabbit).

    Source sentences

    Summary
    Through single-cell RNA sequencing analysis and cell tracing studies, a subset of endothelial progenitor cells, myeloid-derived CD93+/CD34+ cells, was identified as the main contributor to final endothelium regeneration.
    1 context sentence
    Summary · context
    We fabricated 3D PGS-PCL vascular grafts, which presented tunable polymer components, porosity, mechanical strength, and degrading rate.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.